metastatic/advanced RCC (mRCC) - 1st line (L1) | |||
metastatic/advanced RCC (mRCC) - 1st line (L1) | mRCC - L1 - PDL1 negative | mRCC - L1 - PDL1 positive | |
atezolizumab based treatment | |||
atezolizumab alone | IMmotion-150 ... | IMmotion-150 ... | |
atezolizumab plus bevacizumab | IMmotion-150 ... | IMmotion-150 ... |